Short Interest in Tema Oncology ETF (NASDAQ:CANC) Expands By 85.4%

Posted by Lauren Steadman on Jun 4th, 2026

Tema Oncology ETF (NASDAQ:CANC – Get Free Report) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totaling 15,952 shares, a growth of 85.4% from the April 30th total of 8,604 shares. Based on an average daily trading volume, of 17,022 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.3% of the shares of the stock are sold short.

Tema Oncology ETF Stock Performance

CANC stock opened at $36.39 on Thursday. Tema Oncology ETF has a one year low of $23.49 and a one year high of $39.95. The company’s fifty day moving average price is $37.56 and its 200-day moving average price is $36.46. The company has a market capitalization of $170.67 million, a PE ratio of 20.39 and a beta of 0.72.

Institutional Investors Weigh In On Tema Oncology ETF

Several large investors have recently bought and sold shares of CANC. Roxbury Financial LLC bought a new stake in Tema Oncology ETF in the first quarter worth $34,000. Jane Street Group LLC bought a new stake in Tema Oncology ETF in the first quarter worth about $213,000. LPL Financial LLC bought a new position in shares of Tema Oncology ETF in the fourth quarter worth about $278,000. Flow Traders U.S. LLC bought a new position in shares of Tema Oncology ETF in the third quarter worth about $630,000. Finally, Thrivent Financial for Lutherans grew its holdings in shares of Tema Oncology ETF by 891.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after purchasing an additional 1,314,177 shares during the last quarter.

About Tema Oncology ETF

(Get Free Report)

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.